Skip to main content

Gene Expression: Epigenetic and Transcriptional Regulation in Neurodegenerative Diseases and Ageing

65kviews
Editorial12 December 2023
Editorial: Gene expression: epigenetic and transcriptional regulation in neurodegenerative diseases and ageing

Brain database, consolidating Alzheimer's disease (AD) and mild cognitive impairment transcriptomic data from 17 single-cell RNA-Seq (scRNA-Seq) projects sourced from the GEO and Synapse databases. SCAD-Brain encompasses 21 datasets comprising 10 distinct brain regions, 16 primary cells, and 1,564,825 individual cells. Researchers can utilize SCAD-Brain for diverse analyses, including cell diversity, cell marker identification, differential expression, and functional enrichment across brain regions and cell types. It is user-friendly for bench scientists with minimal programming experience, although it's worth noting that these functionalities contribute to a notably slow response from the SCAD-Brain server. In a complementary study, Abdullatef and Farina conducted a comprehensive review of ex-vivo human and mouse central nervous system transcriptomic studies indexed in PubMed. They catalogued and categorized around 100 transcriptomic datasets spanning human and mouse development, aging, and five major NDs, including AD, Parkinson's (PD), Huntington's, Multiple sclerosis, and Amyotrophic lateral sclerosis. Researchers proficient in computational analysis may find these listed datasets valuable.Epigenetic processes involve molecular switches influenced by development, environmental factors, and experiences, regulating gene expression without altering DNA and impacting traits across generations (Jangid et al. 2018). A pivotal mechanism involves the addition or removal of methyl groups from DNA or RNA, orchestrated by methyltransferases and demethylases (Traube and Carell 2017). Methyltransferase-like enzymes, such as METTL3, play a crucial role in depositing methyl groups specifically on the nitrogen atom at the sixth position of the adenine base in RNA, forming N6-methyladenosine (m6A) (Masatoshi Kobayashi and Ueki 2018). This widespread and reversible RNA modification influences RNA stability, splicing, translation, and subsequently, protein production (Adams and Cory 1975;Fu et al. 2014), and have relevance in various diseases, including cancer, neurodevelopmental, and metabolic diseases (Shafik et al. 2021). Methylated RNA Immunoprecipitation Sequencing (MERIP-Seq) is a powerful technique for transcriptome-wide mapping of RNA methylation, with a primary focus on m6A modification (Dominissini et al. 2012).In a comprehensive study, Hu et.al. used MERIP-Seq and RNA-Seq methodologies to investigate genome-wide m6A RNA modifications and transcription profiles in the mouse hippocampus at different developmental stages: postnatal 10 days (P10), 11 weeks (adult), and 64 weeks (aged). The hippocampus, a vital seahorse-shaped brain region responsible for memory consolidation and spatial navigation, underwent spatial cognition and learning impairment in aged mice, as demonstrated by the Barnes maze test. Further analysis revealed differential high expression and m6A methylation of PD-1/PD-L1 pathway genes (Pdcd1, Myd88, and Ptpn6), potentially contributing to cognitive dysfunctions in the aged hippocampus. Additionally, the ectopic expression of Mettl3 was shown to affect the expression of PD-1/PD-L1 pathway genes, leading to a significant spatial cognitive deficit. Their data suggest that m6A mediated by METTL3 contributes to cognitive deficits linked to the hippocampus through the PD-1/PD-L1 pathway in aged mice. It's crucial to note that PD-1/PD-L1 pathway activation has also been shown to protect against inflammatory processes associated with neurodegeneration (Kummer et al. 2021) and autoimmune diseases (Nishimura et al. 2001), while suppressing them in cancers (Yamaguchi et al. 2022;Luke et al. 2023). Therefore, the observed effects of ectopic expression of METTL3 on the activation of the PD-1/PD-L1 pathway in aged mice warrant further investigation.Shifting focus to DNA methyltransferase 1 (DNMT1), responsible for maintaining DNA methylation marks postnatally (Lyko 2018), Wang J et.al investigated genetic variations in DNMT1 among 712 sporadic PD patients and 696 controls in the Chinese population. The study identified the protective allele rs9305012 against sporadic PD, with reduced DNMT1 expression as observed in the postmortem PD brains. Additionally, potential regulatory effects of rs9305012 on P2RY11 gene expression were noted. However, the functional impact of rs9305012 remains uncertain. Nevertheless, genetic variants of DNMT1 and P2RY11 have been associated with narcolepsy in patients with cerebellar ataxia and cataplexy,and consistently, both genes have been expressed in the cerebellum, the region usually not associated with PD, but involved in movement and reward, which may have relevance in the motor dysfunctions in PD (Pedroso et al. 2013;Kornum et al. 2011).Over 30 cell death modalities have been proposed in living organisms, a subject open to debate due to the often-blurred distinction caused by cross-talk and overlapping molecular players and features in various cell death pathways (Galluzzi et al. 2018;Liu et al. 2018). It is not surprising that identifying the molecular mechanisms underlying progressive neuronal loss in NDs is challenging.In a study by Tan Y et al. differentially expressed mRNAs and lncRNAs in AD were identified using GEO microarray datasets. Through various bioinformatics approaches, authors identified lncRNAs that compete with miRNAs, posttranscriptionally regulating differentially expressed mRNAs associated with ferroptosis -a recently discovered iron-dependent death mode (Galluzzi et al. 2018). These lncRNAs are called competitive endogenous RNAs (ceRNAs), which sequester miRNAs by forming complementary bindings with them affecting the translation of thier target mRNAs (Thomson and Dinger 2016). The authors propose that the five ferroptosis-associated genes (EPT1, KLHL24, LRRFIP1, CXCL2, and CD44) differentially expressed in AD are regulated by a network of 28 ceRNAs and their 110 miRNA targets.Further, experimental validation is required to confirm these findings.In another study, Huangwei Wei et.al. identified necroptosis-related genes differentially expressed in AD brains compared to control samples. Necroptosis is a programmed version of necrosis (Galluzzi et al. 2018) Members of Actinobacteria were associated with a higher AD risk, while Ruminococcus showed a protective effect. Further research is needed to confirm these causal relationships.In summary, the research article featured in this topic provides essential resources, a conceptualized bioinformatics approach, and identifies crucial gene regulation mechanisms operational in NDs, enhancing our understanding of the subject. The common theme that emerges from these studies is that the genes directly or indirectly associated with inflammation, auto-immunity, and immune responses are differentially expressed in neurodegenerative diseases and aging.

2,531 views

Unraveling the connection between gut microbiota and Alzheimer’s disease: a two-sample Mendelian randomization analysis
Purpose: Studies have shown a close relationship between gut microbiota (GM) and Alzheimer's disease (AD). However, the causal relationship between them remains unclear.We conducted a genome-wide association study (GWAS) using publicly available summary statistics data for GM and AD. We extracted independent genetic loci significantly associated with GM relative abundances as instrumental variables based on predefined thresholds (P < 1*e − 5). The inverse variance-weighted (IVW) method was primarily used for causal relationship assessment. Additional analyses, including MR-Egger, weighted median, simple mode, and weighted mode, were performed as supplementary analyses.Results: IVW analysis revealed significant correlations between certain microbial taxa and the risk of AD. Higher abundances of Actinobacteria at the class level, phylum. Actinobacteria, class. Deltaproteobacteria, order.Desulfovibrionales, genus.Oscillospira, and genus.Ruminococcaceae UCG004 (p < 0.048) was found to be positively associated with an elevated risk of AD. However, within the genus-level taxa, Ruminococcus1 (p=0.030) demonstrated a protective effect on lowering the risk of AD. In addition, to ensure the robustness of the findings, we employed Cochrane's Q test and leave-one-out analysis for quality assessment, while the stability and reliability of the results were validated through MR-Egger intercept test, MR-PRESSO global test, and sensitivity analysis.This study provided a comprehensive analysis of the causal relationship between 211 GM taxa and AD. It discerned distinct GM taxa linked to the susceptibility of AD, thereby providing novel perspectives on the genetic mechanisms governing AD via the GM. Additionally, these discoveries held promise as valuable biomarkers, enabling the identification of potential therapeutic targets and guiding forthcoming AD investigations.

6,674 views

21 citations

ORIGINAL RESEARCH
6 March 2023
Gene-wide significant association analyses of DNMT1 genetic variants with Parkinson’s disease
Jian-Yong Wang, 7 more and Xiong Zhang

3,249 views

4 citations